WebApr 10, 2024 · Pear Therapeutics Inc. filed for bankruptcy protection under chapter 11 to buy time to sell its assets. The company was the first-to-market for prescription digital therapies, with three PDTs gaining regulatory nods from the FDA: Reset for substance use disorder, Reset-O for opioid use disorder and Somryst for insomnia. WebApr 4, 2024 · Science Communications Manager, Columbia University's Mortimer B. Zuckerman Mind, Brain, and Behavior Institute 1 mgg
Digital Therapeutics & Updates on Payer Coverage
WebSomryst is a support system for those suffering from chronic insomnia, but the support system behind Somryst is Pear's Patient Service Center: a dedicated team of … WebNov 7, 2024 · BOSTON, November 07, 2024--Pear Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe shulker box tooltip mod 1.18.2
Digital therapeutics have potential but commercial success
WebJun 3, 2024 · The study details indicate that the Somryst intervention will deliver cognitive behavioural therapy for insomnia (CBTi) via mobile devices as six treatment core modules over nine weeks. Additionally, the Hugo platform will be used to collect patient-generated engagement data, healthcare use and patient activity/clinical outcomes. WebJun 8, 2024 · Interim results from the DREAM trial showed treatment with Somryst, a prescription digital therapeutic (PDT) for patients with chronic insomnia, achieved … WebAug 10, 2024 · For example, statements that indicate clinical utility and durable economic benefit of patients using Somryst will improve are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “can” or variations of them or similar terminology. shulker box tooltips 1.18.1